Why Is Levetiracetam So Hard to Find? [Explained for 2026]

If you've ever shown up at the pharmacy to pick up your levetiracetam prescription only to hear "we're out of stock," you're not alone. Levetiracetam—sold under brand names like Keppra, Keppra XR, and Spritam—is one of the most widely prescribed antiepileptic drugs in the United States, with more than 6 million prescriptions dispensed annually. Yet despite its popularity, patients regularly struggle to find it in stock. In this article, we'll explain exactly why that happens and what you can do about it.

What Is Levetiracetam and Who Takes It?

Levetiracetam is an antiepileptic drug (AED) approved by the FDA to treat three types of seizures: partial-onset seizures (in patients as young as 1 month), myoclonic seizures in juvenile myoclonic epilepsy (ages 12+), and primary generalized tonic-clonic seizures (ages 6+). It's also used off-label for status epilepticus and seizure prevention after traumatic brain injury.

Because epilepsy is a chronic condition requiring daily medication, patients who take levetiracetam cannot simply skip doses without serious risk. Missing even a single dose can trigger breakthrough seizures. This makes the stakes of a pharmacy shortage extremely high—and the frustration entirely understandable.

Has There Been a Levetiracetam Shortage?

Yes—and it has happened more than once. The most significant national shortage of generic levetiracetam oral tablets occurred in 2019–2020, when the FDA officially listed multiple generic manufacturers as having supply disruptions. The Epilepsy Foundation publicly warned patients and urged them to call for refills early and call around to multiple pharmacies. By early 2020, availability was improving but not fully resolved.

More recently, the injectable (IV) formulation of levetiracetam experienced supply disruptions in 2024, and certain UK brands of levetiracetam tablets faced regional shortages into early 2025. A 2024 survey of epilepsy patients found that 62.8% had reported difficulty finding levetiracetam—a striking figure for a medication that is generally not considered to be in a nationwide shortage.

As of 2026, oral levetiracetam immediate-release tablets are largely available at most U.S. pharmacies. However, spot shortages—where one pharmacy is out of stock while another nearby has plenty—continue to occur.

Why Does Levetiracetam Go Out of Stock?

Several structural factors make levetiracetam vulnerable to supply disruptions:

• Generic market fragmentation: The generic levetiracetam market includes many manufacturers—including Apotex, Lupin, Torrent, Sun Pharma, Teva, and others. When even one major manufacturer pauses production for quality control, raw material issues, or regulatory reasons, pharmacies that rely on that source can suddenly find themselves short.
• Just-in-time pharmacy inventory: Large pharmacy chains often use just-in-time ordering systems that minimize on-hand stock. This means any disruption in the supply chain quickly translates to empty shelves at individual store locations.
• High demand volume: With 6+ million prescriptions per year, levetiracetam is a very high-volume product. Even a modest increase in demand—or a small reduction in supply from one manufacturer—can ripple across the system.
• Multiple formulations: Levetiracetam comes in immediate-release tablets, extended-release tablets, oral solution, orally disintegrating tablets, and IV formulations—each with its own supply chain. Shortages in one formulation don't necessarily mean another is unavailable, but they complicate patients' options.
• Active ingredient sourcing: Like many generic drugs, the active pharmaceutical ingredient (API) for levetiracetam is largely sourced from manufacturers in India and China. Geopolitical factors, regulatory inspections, or raw material price spikes can all create upstream shortages.

Is Levetiracetam a Controlled Substance?

No. Levetiracetam is not a controlled substance under U.S. federal law. It has no DEA scheduling, no refill restrictions, and does not carry the regulatory burdens that make controlled substance prescriptions harder to fill. This is one reason why—unlike shortages of controlled substances such as Adderall—levetiracetam shortages are primarily driven by supply chain issues rather than regulatory quota limits.

What Happens When a Patient Can't Find Levetiracetam?

The consequences can be serious. Epilepsy is not a condition where a medication holiday is safe. Running out of levetiracetam abruptly can cause:

• Breakthrough seizures, even if the patient has been seizure-free for months or years
• Status epilepticus (a seizure lasting more than 5 minutes, which is a medical emergency)
• Loss of driving privileges if a new seizure occurs
• Anxiety, stress, and disruption to daily life

This is why finding levetiracetam quickly—when your usual pharmacy is out—matters so much.

What Can You Do If Your Pharmacy Is Out of Levetiracetam?

Here are your best options when your pharmacy can't fill your prescription:

1. Call multiple pharmacies: Stock varies significantly between locations, even within the same chain. Don't stop at the first "no."
2. Ask about a different formulation: If your 500 mg tablets are out of stock, 250 mg tablets from the same or different manufacturer might be available. Ask your doctor about switching temporarily.
3. Ask about a different manufacturer: Pharmacies can sometimes order from a different generic supplier if their usual source is out.
4. Use medfinder: medfinder calls pharmacies near you to find which ones have your medication in stock, so you don't have to spend hours on the phone. Visit medfinder.com to get started.
5. Contact your prescriber: Your neurologist or epilepsy specialist may have a bridge supply, samples, or contacts at specialty pharmacies that can help in an emergency.

Prevention: How to Avoid Running Out

The best strategy for levetiracetam is proactive management. Call in your refill 7–10 days before you run out. If your pharmacy regularly struggles to stock it, consider asking your doctor for a 90-day supply, which may be available through mail-order pharmacies and can also save you money.

For more tips on locating your medication, see our guide: How to Find Levetiracetam in Stock Near You.

Bottom Line

Levetiracetam shortages are real, recurring, and driven by a complex mix of generic market dynamics, supply chain vulnerabilities, and just-in-time inventory practices. While the situation has improved significantly since the worst shortages of 2019–2020, spot shortages at individual pharmacies remain common. The good news: levetiracetam is not a controlled substance, which means there are no regulatory barriers to switching pharmacies or formulations. With the right approach—and tools like medfinder—you can usually locate what you need without putting your seizure control at risk.